AR018528A1 - Mezcla polimerica biodegradable de micelas para transferencia genetica - Google Patents

Mezcla polimerica biodegradable de micelas para transferencia genetica

Info

Publication number
AR018528A1
AR018528A1 ARP980106330A ARP980106330A AR018528A1 AR 018528 A1 AR018528 A1 AR 018528A1 AR P980106330 A ARP980106330 A AR P980106330A AR P980106330 A ARP980106330 A AR P980106330A AR 018528 A1 AR018528 A1 AR 018528A1
Authority
AR
Argentina
Prior art keywords
nucleic acid
copolymer
polyester
sugar
host cell
Prior art date
Application number
ARP980106330A
Other languages
English (en)
Original Assignee
Expression Genetics Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Expression Genetics Inc filed Critical Expression Genetics Inc
Publication of AR018528A1 publication Critical patent/AR018528A1/es

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N11/00—Carrier-bound or immobilised enzymes; Carrier-bound or immobilised microbial cells; Preparation thereof
    • C12N11/02—Enzymes or microbial cells immobilised on or in an organic carrier
    • C12N11/06—Enzymes or microbial cells immobilised on or in an organic carrier attached to the carrier via a bridging agent
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K48/00—Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy
    • A61K48/0008—Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy characterised by an aspect of the 'non-active' part of the composition delivered, e.g. wherein such 'non-active' part is not delivered simultaneously with the 'active' part of the composition
    • A61K48/0025—Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy characterised by an aspect of the 'non-active' part of the composition delivered, e.g. wherein such 'non-active' part is not delivered simultaneously with the 'active' part of the composition wherein the non-active part clearly interacts with the delivered nucleic acid
    • A61K48/0041—Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy characterised by an aspect of the 'non-active' part of the composition delivered, e.g. wherein such 'non-active' part is not delivered simultaneously with the 'active' part of the composition wherein the non-active part clearly interacts with the delivered nucleic acid the non-active part being polymeric
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K48/00—Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A61K9/107—Emulsions ; Emulsion preconcentrates; Micelles
    • A61K9/1075—Microemulsions or submicron emulsions; Preconcentrates or solids thereof; Micelles, e.g. made of phospholipids or block copolymers
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/87—Introduction of foreign genetic material using processes not otherwise provided for, e.g. co-transformation
    • C12N15/88—Introduction of foreign genetic material using processes not otherwise provided for, e.g. co-transformation using microencapsulation, e.g. using amphiphile liposome vesicle
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S977/00—Nanotechnology
    • Y10S977/902—Specified use of nanostructure
    • Y10S977/904—Specified use of nanostructure for medical, immunological, body treatment, or diagnosis
    • Y10S977/906—Drug delivery
    • Y10S977/907—Liposome
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S977/00—Nanotechnology
    • Y10S977/902—Specified use of nanostructure
    • Y10S977/904—Specified use of nanostructure for medical, immunological, body treatment, or diagnosis
    • Y10S977/915—Therapeutic or pharmaceutical composition
    • Y10S977/916—Gene therapy

Abstract

Una mezcla polimérica biodegradable de micelas utilizada para introducir un ácido nucleico seleccionado enuna célula huésped determinada, cuyo contenido esun copolímero anfifílico de poliéster-polication y un copolímero anfifílico depoliéster-azucar . El copolímero de poliéster-polication forma una interaccionelectrostática con ácidos nucleicos polianionicos y el copolímero de poliéster-azucar dirige el complejo de micelas-ácido nucleico a las células in vivo.También puedenincluirse otros copol ímeros con propiedades similares. La composicion optimiza la eficiencia de introduccion mediante un transportador de genesparticulado, para lo cual se controlan fácilmente mediante multivariados medios, el tamano de lapartícula y la densidad de carg a. Asimismo, puedenincorporarse diversas clases de ligandos y otros compuestos funcionales. La composicion puede utilizarse en un método para transformar una célula huéspeddeterminada con un ácido nucleicoseleccionado.
ARP980106330A 1997-12-12 1998-12-11 Mezcla polimerica biodegradable de micelas para transferencia genetica AR018528A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US6955197P 1997-12-12 1997-12-12

Publications (1)

Publication Number Publication Date
AR018528A1 true AR018528A1 (es) 2001-11-28

Family

ID=22089740

Family Applications (1)

Application Number Title Priority Date Filing Date
ARP980106330A AR018528A1 (es) 1997-12-12 1998-12-11 Mezcla polimerica biodegradable de micelas para transferencia genetica

Country Status (13)

Country Link
US (1) US6210717B1 (es)
EP (1) EP1037611B1 (es)
JP (1) JP4570776B2 (es)
KR (1) KR20010032878A (es)
CN (1) CN1281355A (es)
AR (1) AR018528A1 (es)
AT (1) ATE412403T1 (es)
AU (1) AU740342B2 (es)
BR (1) BR9813548A (es)
DE (1) DE69840175D1 (es)
IL (1) IL136681A0 (es)
WO (1) WO1999029303A1 (es)
ZA (1) ZA9811376B (es)

Families Citing this family (84)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1999034831A1 (en) * 1998-01-05 1999-07-15 University Of Washington Enhanced transport using membrane disruptive agents
WO2002085337A1 (en) * 2001-04-20 2002-10-31 The University Of British Columbia Micellar drug delivery systems for hydrophobic drugs
SE9904581D0 (sv) * 1999-12-15 1999-12-15 A & Science Invest Ab A novel helicobacter pylori-binding substance and use thereof
AU2764801A (en) * 2000-01-07 2001-07-24 University Of Washington Enhanced transport of agents using membrane disruptive agents
US20030134420A1 (en) * 2000-02-18 2003-07-17 Lollo Charles Peter Methods and compositions for gene delivery
WO2001093836A2 (en) * 2000-06-09 2001-12-13 Teni Boulikas Encapsulation of polynucleotides and drugs into targeted liposomes
US20030072794A1 (en) * 2000-06-09 2003-04-17 Teni Boulikas Encapsulation of plasmid DNA (lipogenes™) and therapeutic agents with nuclear localization signal/fusogenic peptide conjugates into targeted liposome complexes
US7265186B2 (en) * 2001-01-19 2007-09-04 Nektar Therapeutics Al, Corporation Multi-arm block copolymers as drug delivery vehicles
TWI246524B (en) 2001-01-19 2006-01-01 Shearwater Corp Multi-arm block copolymers as drug delivery vehicles
CA2440935A1 (en) * 2001-03-13 2002-09-19 Richard Liggins Micellar drug delivery vehicles and precursors thereto and uses thereof
US20030157170A1 (en) * 2001-03-13 2003-08-21 Richard Liggins Micellar drug delivery vehicles and precursors thereto and uses thereof
KR100566911B1 (ko) * 2001-06-25 2006-04-03 주식회사 삼양사 약물 전달체용 음이온기-함유 양친성 블록 공중합체 및 그의 양이온성 약물과의 복합체
US6967234B2 (en) 2002-12-18 2005-11-22 Ethicon, Inc. Alkyd-lactone copolymers for medical applications
US7034037B2 (en) 2001-06-29 2006-04-25 Ethicon, Inc. Compositions and medical devices utilizing bioabsorbable polymeric waxes and rapamycin
US7030127B2 (en) 2001-06-29 2006-04-18 Ethicon, Inc. Composition and medical devices utilizing bioabsorbable polymeric waxes
WO2003078576A2 (en) * 2002-03-12 2003-09-25 Nitto Denko Corporation Vector for transfection of eukaryotic cells
US7326426B2 (en) 2002-03-29 2008-02-05 Ethicon, Inc. Compositions and medical devices utilizing bioabsorbable liquid polymers
US7005136B2 (en) 2002-03-29 2006-02-28 Ethicon, Inc. Bone replacement materials utilizing bioabsorbable liquid polymers
WO2003090807A1 (en) * 2002-04-24 2003-11-06 Poly-Med, Inc. Multifaceted endovascular stent coating for preventing restenosis
US7368125B2 (en) 2002-06-05 2008-05-06 Ethicon, Inc. Amphiphilic polymers for medical applications
AR037006A1 (es) * 2002-06-20 2004-10-20 S I G Sist S De Identificacion Marcador de objetos a identificar consistente en al menos un fragmento de adn.
US7026374B2 (en) 2002-06-25 2006-04-11 Aruna Nathan Injectable microdispersions for medical applications
US7101566B2 (en) 2002-06-28 2006-09-05 Ethicon, Inc. Polymer coated microparticles for sustained release
MY148805A (en) 2002-10-16 2013-05-31 Takeda Pharmaceutical Controlled release preparation
GB0228525D0 (en) * 2002-12-06 2003-01-15 Univ Cambridge Tech Polymers and their use
US20040115226A1 (en) * 2002-12-12 2004-06-17 Wenji Li Free-flowing solid formulations with improved bio-availability of poorly water soluble drugs and process for making the same
US6872799B2 (en) 2002-12-18 2005-03-29 Ethicon, Inc. Functionalized polymers for medical applications
US6866860B2 (en) 2002-12-19 2005-03-15 Ethicon, Inc. Cationic alkyd polyesters for medical applications
US7135523B2 (en) * 2003-03-14 2006-11-14 Industrial Technology Research Institute Nanoscale helical microstructures and channels from chiral poly(L-lactide) block containing block copolymers
SE0300805D0 (sv) * 2003-03-25 2003-03-25 Biacore Ab Immobilization method and kit therefor
WO2004086046A1 (en) * 2003-03-25 2004-10-07 Biacore Ab Immobilization method and kit therefor
US7309757B2 (en) * 2003-06-20 2007-12-18 Agency For Science, Technology And Research Polymers for the delivery of bioactive agents and methods of their preparation
US8062891B2 (en) 2003-10-24 2011-11-22 Gencia Corporation Nonviral vectors for delivering polynucleotides to plants
US8133733B2 (en) 2003-10-24 2012-03-13 Gencia Corporation Nonviral vectors for delivering polynucleotides to target tissues
US20090208478A1 (en) * 2003-10-24 2009-08-20 Gencia Corporation Transducible polypeptides for modifying metabolism
US8507277B2 (en) 2003-10-24 2013-08-13 Gencia Corporation Nonviral vectors for delivering polynucleotides
CA2543257C (en) 2003-10-24 2013-12-31 Gencia Corporation Methods and compositions for delivering polynucleotides
US20090123468A1 (en) 2003-10-24 2009-05-14 Gencia Corporation Transducible polypeptides for modifying metabolism
US20050238675A1 (en) * 2004-04-26 2005-10-27 Wenjie Li Water-soluble formulations of fat soluble vitamins and pharmaceutical agents and their applications
EP1765403A4 (en) * 2004-05-10 2011-03-30 Univ Utah Res Found COMBINED ACTIVE AND PASSIVE TARGETING OF BIOLOGICALLY ACTIVE ACTIVE SUBSTANCES
CN101115471B (zh) * 2005-02-17 2011-02-09 梅迪沃什有限公司 聚合物颗粒输送组合物及使用方法
WO2007011802A1 (en) * 2005-07-18 2007-01-25 Nektar Therapeutics Al, Corporation Method for preparing branched functionalized polymers using branched polyol cores
KR20080064827A (ko) 2005-10-05 2008-07-09 도쿄 씨알오 가부시키가이샤 생체 적합성 블록 공중합체, 그 용도 및 제조법
US7718193B2 (en) * 2006-03-16 2010-05-18 University Of Washington Temperature- and pH-responsive polymer compositions
CN101595214B (zh) * 2006-11-29 2013-06-12 诺维信股份有限公司 改进向细菌细胞中导入dna的方法
US7981688B2 (en) 2007-03-08 2011-07-19 University Of Washington Stimuli-responsive magnetic nanoparticles and related methods
JP5270884B2 (ja) * 2007-09-03 2013-08-21 大阪瓦斯株式会社 分散剤およびこの分散剤を含むポリ乳酸系複合樹脂粒子
WO2009100645A1 (en) * 2008-01-25 2009-08-20 Tuo Jin Polycationic gene carriers formed of endogenous amino group-bearing monomers
US9476063B2 (en) 2008-05-13 2016-10-25 University Of Washington Diblock copolymers and polynucleotide complexes thereof for delivery into cells
KR101764427B1 (ko) 2008-05-13 2017-08-02 유니버시티 오브 워싱톤 미셀성 어셈블리
JP2011523641A (ja) 2008-05-13 2011-08-18 ユニヴァーシティ オブ ワシントン 高分子キャリア
EP2331069A4 (en) 2008-08-22 2011-10-26 Univ Washington HETEROGENEOUS POLYMER MICELLES FOR INTRACELLULAR DELIVERY
US9464300B2 (en) 2008-11-06 2016-10-11 University Of Washington Multiblock copolymers
US8822213B2 (en) 2008-11-06 2014-09-02 University Of Washington Bispecific intracellular delivery vehicles
WO2010077678A2 (en) 2008-12-08 2010-07-08 University Of Washington Omega-functionalized polymers, junction-functionalized block copolymers, polymer bioconjugates, and radical chain extension polymerization
AU2009331027B2 (en) * 2008-12-26 2012-12-13 Samyang Holdings Corporation Preparation method of polymeric micellar nanoparticles composition containing a poorly water-soluble drug
EP2201935B1 (en) * 2008-12-26 2020-07-08 Samyang Biopharmaceuticals Corporation Polymeric micelle composition containing a poorly soluble drug and preparation method of the same
WO2010114768A1 (en) * 2009-03-30 2010-10-07 Cerulean Pharma Inc. Polymer-epothilone conjugates, particles, compositions, and related methods of use
WO2010114770A1 (en) * 2009-03-30 2010-10-07 Cerulean Pharma Inc. Polymer-agent conjugates, particles, compositions, and related methods of use
EA201171195A8 (ru) * 2009-03-30 2014-08-29 Серулин Фарма Инк. Конъюгаты, частицы, композиции "полимер-агент" и способы их применения
US8426214B2 (en) * 2009-06-12 2013-04-23 University Of Washington System and method for magnetically concentrating and detecting biomarkers
US9080933B2 (en) 2009-11-09 2015-07-14 University Of Washington Through Its Center For Commercialization Stimuli-responsive polymer diagnostic assay comprising magnetic nanoparticles and capture conjugates
US20110117668A1 (en) * 2009-11-09 2011-05-19 University Of Washington Through Its Center For Commercialization Self-powered smart diagnostic devices
US9415113B2 (en) 2009-11-18 2016-08-16 University Of Washington Targeting monomers and polymers having targeting blocks
US8765098B2 (en) 2010-03-30 2014-07-01 International Business Machines Corporation Star polymers, methods of preparation thereof, and uses thereof
EP2658567A4 (en) 2010-12-28 2014-09-24 Univ Rochester METHOD FOR MODIFYING INSULIN SIGNAL TRANSMISSION BY BILIVERDINREDUCTASE (BVR) AND BVR-DERIVED PEPTIDES
EP2661454A4 (en) * 2011-01-06 2014-12-10 Univ Shanghai Jiaotong CATIONIC POLYMERS FORMED FROM MONOMERS HAVING AMINO GROUPS AND HETEROCYCLIC COUPLERS
CA2839526A1 (en) 2011-06-23 2012-12-27 Dsm Ip Assets B.V. Micro- or nanoparticles comprising a biodegradable polyesteramide copolymer for use in the delivery of bioactive agents
US9873765B2 (en) 2011-06-23 2018-01-23 Dsm Ip Assets, B.V. Biodegradable polyesteramide copolymers for drug delivery
CN102516534B (zh) * 2011-11-14 2013-11-20 上海交通大学 可降解为精胺的聚阳离子及其合成方法、纳米颗粒
EP2908853B1 (en) 2012-10-21 2018-12-05 University Of Rochester Thy1 (cd90) as a therapy to control adipose tissue accumulation
AU2014296278C1 (en) 2013-07-30 2023-02-02 Genevant Sciences Gmbh Block copolymers and their conjugates or complexes with oligonucleotides
EP3033108B1 (en) 2013-08-16 2021-03-24 University Of Rochester Designed peptides for tight junction barrier modulation
JP6564369B2 (ja) 2013-12-09 2019-08-21 デュレクト コーポレイション 薬学的活性剤複合体、ポリマー複合体、ならびにこれらを伴う組成物及び方法
CN106102777B (zh) * 2013-12-27 2019-12-17 林希龙 用于生物体内及体外递送核酸系药物的新颖糖醇系组成物
CA2969171C (en) 2014-12-18 2023-12-12 Dsm Ip Assets B.V. Drug delivery system for delivery of acid sensitive drugs
AU2016209295B2 (en) 2015-01-21 2021-08-12 Genevant Sciences Gmbh Methods, compositions, and systems for delivering therapeutic and diagnostic agents into cells
CN104829786A (zh) * 2015-05-04 2015-08-12 中国科学院上海有机化学研究所 侧挂天然半乳糖和赖氨酸的阳离子大分子、制备方法及其用途
ES2907486T3 (es) 2015-09-24 2022-04-25 Univ North Carolina Chapel Hill Métodos y composiciones para reducir metástasis
CA3008788C (en) * 2015-12-18 2021-05-25 Samyang Biopharmaceuticals Corporation Method for preparing polymeric micelles containing an anionic drug
EP3562510A4 (en) 2016-12-30 2021-01-06 Genevant Sciences GmbH BRANCHED PEG MOLECULES AND ASSOCIATED COMPOSITIONS AND PROCEDURES
WO2019049862A1 (ja) * 2017-09-05 2019-03-14 味の素株式会社 ポリリジン誘導体
WO2019129657A1 (en) 2017-12-28 2019-07-04 Fundació Hospital Universitari Vall D'hebron - Institut De Recerca Actively targeted polymeric micelles for drug and gene delivery
WO2020247347A1 (en) 2019-06-05 2020-12-10 University Of Rochester New designed inhibitors of tight junction formation

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3808531C1 (es) 1988-03-15 1989-07-13 Eppendorf - Netheler - Hinz Gmbh, 2000 Hamburg, De
US5501662A (en) 1992-05-22 1996-03-26 Genetronics, Inc. Implantable electroporation method and apparatus for drug and gene delivery
US5273525A (en) 1992-08-13 1993-12-28 Btx Inc. Injection and electroporation apparatus for drug and gene delivery
WO1995003356A1 (en) * 1993-07-23 1995-02-02 Massachusetts Institute Of Technology Nanoparticles and microparticles of non-linear hydrophilic-hydrophobic multiblock copolymers
DE69534780T2 (de) * 1994-04-08 2006-10-05 Qlt Usa Inc., Fort Collins Flüssige Zusammensetzungen zur Arzneistoffabgabe
US5752974A (en) * 1995-12-18 1998-05-19 Collagen Corporation Injectable or implantable biomaterials for filling or blocking lumens and voids of the body

Also Published As

Publication number Publication date
EP1037611A1 (en) 2000-09-27
ATE412403T1 (de) 2008-11-15
EP1037611B1 (en) 2008-10-29
JP2001525357A (ja) 2001-12-11
CN1281355A (zh) 2001-01-24
KR20010032878A (ko) 2001-04-25
WO1999029303A1 (en) 1999-06-17
AU1910899A (en) 1999-06-28
IL136681A0 (en) 2001-06-14
DE69840175D1 (de) 2008-12-11
EP1037611A4 (en) 2006-09-20
JP4570776B2 (ja) 2010-10-27
BR9813548A (pt) 2000-10-10
US6210717B1 (en) 2001-04-03
ZA9811376B (en) 1999-06-28
AU740342B2 (en) 2001-11-01

Similar Documents

Publication Publication Date Title
AR018528A1 (es) Mezcla polimerica biodegradable de micelas para transferencia genetica
Zimmerman et al. Macromolecular crowding allows blunt-end ligation by DNA ligases from rat liver or Escherichia coli.
DE50006269D1 (de) Kombinationen zur einführung von nucleinsäuren in zellen
WO2002039955A3 (en) Biodegradable mixed polymeric micelles for drug delivery
JP2013255517A5 (es)
WO1997025067A3 (en) Polymers
SE9904475D0 (sv) Nucleic acid delivery system
SG129261A1 (en) Polymers, their preparation and uses
ATE408699T1 (de) Verabreichung von nukleinsäuren und proteinen an zellen
Klermund et al. Polymersomes as nanoreactors for preparative biocatalytic applications: current challenges and future perspectives
AU2003234196A1 (en) Functionalized nanoparticles and methods of use
Kabanov Basic properties of soluble interpolyelectrolyte complexes applied to bioengineering and cell transformations
ATE417897T1 (de) Sulfonierte 8,9 benzophenoxazinfarbstoffe und die verwendung ihrer markierten konjugate
Minko et al. Materials with built-in logic
EP0697906B1 (en) Artificial receptors, antibodies, and enzymes
Pitha Vinyl polymer analogues of nucleic acids
Goh et al. Nano‐to‐Macroscale Poly (methyl methacrylate) Stereocomplex Assemblies
AR013017A1 (es) Composicion que incluye un acido nucleico seleccionado y metodo para su incorporacion en una celula blanco
CA2101332A1 (en) Antibody polycation conjugates
WO2002042426A3 (en) Carrier system for specific artery wall gene delivery
US5440025A (en) Process for separating nucleic acid polymers
Bromberg et al. Bioactive surfaces via immobilization of self-assembling polymers onto hydrophobic materials
Harada et al. Preparation of temperature‐responsive polymer gels physically immobilizing core‐shell type bioconjugates
El‐Masry et al. Amphoteric hydrogels for immobilization of enzymes using template polymerization technique
Katayose et al. PEG-Poly (lysine) block copolymer as a novel type of synthetic gene vector with supramolecular structure

Legal Events

Date Code Title Description
FA Abandonment or withdrawal